Important biomarkers have been found in extracellular vesicles in dogs with myxomatous mitral valve disease and congestive heart failure. This is the first biomarker discovery based on extracellular vesicles in a veterinary disease. These findings could provide important insight into the molecular basis, diagnosis and therapies for myxomatous mitral valve disease in dogs, as well as mitral valve prolapse, a similar disease in humans.